Dashboard
Poor Management Efficiency with a low ROE of 9.80%
- The company has been able to generate a Return on Equity (avg) of 9.80% signifying low profitability per unit of shareholders funds
Flat results in Sep 26
Stock is technically in a Mildly Bearish range
Below par performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
INR 163 Cr (Micro Cap)
27.00
37
0.00%
-0.03
4.40%
1.16
Total Returns (Price + Dividend) 
Syschem (India) for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Syschem (India) Ltd is Rated Sell
Syschem (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 04 Aug 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 19 November 2026, providing investors with the latest perspective on the company’s position.
Read More
Syschem (India) Ltd is Rated Sell
Syschem (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 October 2026, providing investors with the most recent insights into its performance and outlook.
Read More
Syschem (India) Ltd Valuation Shifts Signal Changing Market Sentiment
Syschem (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, coupled with its current financial metrics and market performance, offers investors a fresh perspective on the stock’s price attractiveness amid a challenging industry backdrop.
Read More Announcements 
Announcement Under Regulation 30 Of SEBI (LODR) 2015 : Intimation For Receipt Of Resignation Letter By Director.
13-Nov-2026 | Source : BSEPursuant to regulation 30 of SEBI (Listing Obligation and disclosure requirements) 2015: Intimation of receipt of resignation letter from Whole time Executive Director of the company.
General Update: In In Response To The Query Dated 30Th October 2026 By BSE We Are Hereby Again Submitting The Results For The Quarter Ended 30Th September 2026 With Limited Review Report.
31-Oct-2026 | Source : BSEUpdating of limited review report for the quarter ended 30th September 2026
Newspaper Advertisements For The Unaudited Results For The Quarter And Half Year Ended 30.09.2026.
28-Oct-2026 | Source : BSEAs per regulation 47 of SEBI (Listing Obligations and disclosure requirements 2015: Newspaper advertisements for the for the quarter ended 30.09.2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
Syschem (India) Ltd has announced 10:1 stock split, ex-date: 12 Dec 14
No Bonus history available
Syschem (India) Ltd has announced 1:4 rights issue, ex-date: 28 Sep 23
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Virendra Popatlal Shah (11.98%)
Ashika Global Finance Pvt. Ltd. (4.24%)
27.64%
Quarterly Results Snapshot (Standalone) - Sep'26 - YoY
YoY Growth in quarter ended Sep 2026 is 9.38% vs 118.01% in Sep 2025
YoY Growth in quarter ended Sep 2026 is 0.53% vs 396.88% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 57.66% vs 68.37% in Sep 2024
Growth in half year ended Sep 2025 is 814.00% vs -117.92% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 66.54% vs 71.69% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 0.00% vs -100.00% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 72.99% vs 66.96% in Mar 2025
YoY Growth in year ended Mar 2026 is 2,276.09% vs -83.33% in Mar 2025